Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Telefonica Brasil reports 7.1% revenue growth and higher profits in Q2 2025

Telefonica Brasil (Vivo) increased total revenue in Q2 2025 by 7.1% to 14.6 billion reais and net income by 13.5% to 2.4 billion reais, with an improved EBITDA margin of 40.5%. The company significantly expanded FTTH connections, extended 5G coverage and plans to sell copper and real estate assets worth 4.5 billion reais to finance further investments. » More on de.investing.com
Vivo V60 delivers flagship-level portrait photography at mid-range price

The Vivo V60 pairs Zeiss‑branded 50MP main and telephoto front cameras with Vivo's advanced image processing to produce flagship-quality portrait shots at an estimated $400–$500 price point. It runs on Qualcomm Snapdragon 7 Gen 4 with 12GB RAM, a large 6,500 mAh battery and a premium glass design, trading a mediocre ultra-wide camera for superior telephoto portraits. The review concludes the V60 offers exceptional camera value within the mid-range segment. » More on forbes.com

Historical dividends Dividends

All dividend metrics All metrics

In 2021, VIVO Cannabis has already paid €0.0317 in dividends. The last payout was in June 2021.

Financials

In the last year, VIVO Cannabis had revenue of €17.46m and net profit of -€33.26m

(EUR)	2022	YoY
Revenue	17.46m	0.40%
Gross profit	2.99m	454.42%
Net profit	-33.26m	31.36%
EBITDA	1.32m	102.35%

Fundamentals

Metric	Value
Market capitalization	€5.91m
Number of shares	370.9m
52-week high/low	€0.0478 - €0.00955
Dividends	No
Beta	2.12
P/E ratio	-0.19
PEG ratio	0.01
P/B ratio	0.24
P/S ratio	0.36

Company profile

VIVO Cannabis Inc. produces and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. It offers dried cannabis flower products, pre-rolls, and cannabis oils; and cannabis-derived products under the Canna Farms, Beacon Medical, Fireside, and Lumina brands. The company also operates a network of medical cannabis clinics under the Harvest Medicine brand; and HMED Connect telemedicine platform, an online medical cannabis platform. In addition, it engages in the ethanol extraction, product formulation, and EU-GMP related processes. The company is headquartered in Napanee, Canada.